HIGHLIGHTS
- who: Xin Yan et al. from the State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China have published the article: Efficacy and Safety of First-Line Targeted Treatment and Immunotherapy for Patients with Biliary Tract Cancer: A Systematic Review and Meta-Analysis, in the Journal: Cancers 2022, x of 11/01/2022
- what: This study shows that immunotherapy combined with chemotherapy as first-line treatment can provide survival benefits by improving the objective response rate for patients with unresectable biliary tract cancer. This systematic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.